| Active substance | Vedolizumab |
| Holder | Takeda |
| Status | Closed |
| Indication | Patients with ulcerative colitis that have failed at least 2 previous anti-TNF or for whom anti-TNF are contra-indicated |
| Public documents | Approbation |
| Information for the patient | |
| Informed consent | |
| Last update | 24/03/2015 |
Entyvio®
Last updated on 10/09/2024